International HIV Antiretroviral Adherence, Resistance and Survival
NCT01596322 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 750
Last updated 2017-10-31
Summary
Real-time Wireless Adherence Monitoring to HIV Antiretroviral Therapy in Rural Uganda.
Conditions
Sponsors & Collaborators
-
University of California, San Francisco
collaborator OTHER -
Department of Health and Human Services
collaborator FED -
Mbarara University of Science and Technology
collaborator OTHER -
University of British Columbia
collaborator OTHER - collaborator OTHER
-
Massachusetts General Hospital
lead OTHER
Principal Investigators
-
Jessica Haberer, MD · Massachusetts General Hospital
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2004-09-30
- Primary Completion
- 2015-09-30
- Completion
- 2015-09-30
Countries
- Uganda
Study Locations
More Related Trials
-
Interrupting HIV and TB Stigma in the Household in Uganda
NCT05124665 ·Status: COMPLETED ·Phase: NA
-
Feasibility of Identifying, Enrolling and Following Acute and Early HIV-1 Infected Individuals.
NCT05372510 ·Status: UNKNOWN
-
Peer-led Implementation of TB-HIV Education and Adherence Counseling in Uganda
NCT05917210 ·Status: RECRUITING ·Phase: NA
-
Gene Expression in HIV and Tuberculosis Co-infection
NCT01611402 ·Status: COMPLETED
-
Effectiveness of Intensive Adherence Counselling Among People Living With HIV/AIDS With Low-level Viraemia in Uganda.
NCT05514418 ·Status: UNKNOWN ·Phase: NA
-
Screening for Tuberculosis in HIV-infected Patients Eligible for Antiretroviral Treatment
NCT01433796 ·Status: COMPLETED
-
Enhanced TB Screening to Determine the Prevalence and Incidence of TB in Patients With HIV
NCT02043067 ·Status: COMPLETED
-
Anti-HIV Drugs for Ugandan Patients With HIV and Tuberculosis
NCT00078247 ·Status: COMPLETED ·Phase: PHASE3
-
Pharmacologic Strategies for the Etonogestrel Implant in HIV-Infected Women
NCT03282799 ·Status: COMPLETED ·Phase: PHASE2
-
Nutritional Support for HIV-Tuberculosis Co-infected Adults in Senegal, West Africa
NCT03711721 ·Status: COMPLETED ·Phase: NA
-
A Trial of Same-Day Testing and Treatment to Improve Outcomes Among Symptomatic Patients Newly Diagnosed With HIV
NCT03154320 ·Status: COMPLETED ·Phase: NA
-
UNCPM 22322 - Adaption of the Transition of Care Model for Post-Discharge HIV-NCD Care in Lilongwe, Malawi - MLATHO
NCT06931431 ·Status: RECRUITING ·Phase: NA
-
Viral and Immunologic Factors Contributing to the Lack of HIV Transmission Among Couples in Rakai, Uganda
NCT00342160 ·Status: COMPLETED
-
A Pilot Study of Pre-Exposure Prophylaxis (PrEP) to Evaluate Safety, Acceptability, and Adherence in At-risk Populations in Uganda, Africa
NCT00931346 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Integrating HIV Prevention With TB Household Contact Evaluation in Uganda
NCT07119359 ·Status: RECRUITING ·Phase: NA
-
An Adaptive Randomized Controlled Trial
NCT05633056 ·Status: RECRUITING ·Phase: NA
-
An Enhanced Package of Care to Reduce Reduce Mortality in Advanced HIV Disease
NCT05085171 ·Status: RECRUITING ·Phase: PHASE3
-
Cotrimoxazole Prophylaxis Cessation Study Among Stabilized HIV-Infected Adult Patients on HAART in Entebbe, Uganda
NCT00674921 ·Status: UNKNOWN ·Phase: PHASE4
-
Effectiveness of Directly Observed Therapy in Combined HIV and Tuberculosis Treatment in Resource-limited Settings
NCT00091936 ·Status: COMPLETED ·Phase: NA
-
Observational Study of Specificity of Mycobacterium Tuberculosis Screening and Diagnostics in HIV-Infected Individuals
NCT00865826 ·Status: COMPLETED
-
Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis
NCT01315301 ·Status: UNKNOWN ·Phase: NA
-
Evaluation of the Integration of Ag-RDTs for COVID-19 in MNCH, HIV and TB Services in Cameroon and Kenya
NCT05498727 ·Status: COMPLETED
-
Pre-ART Retention in Care in Tanzania
NCT01992887 ·Status: COMPLETED
-
Characteristics and Outcomes of TB and HIV Co-infections
NCT06531772 ·Status: RECRUITING
-
The Effectiveness of a Mobile Interactive Supervised Therapy (MIST) Intervention for Improving Adherence to HIV Medication
NCT03794648 ·Status: COMPLETED ·Phase: NA